Barbara Morollo

Barbara Morollo is an experienced leader in pharmacovigilance and risk management, currently serving as the Executive Director and Head of Global Safety Science at Ultragenyx Pharmaceutical Inc. since February 2021. Prior roles include Head of Pharmacovigilance at Corbus Pharmaceuticals and various consulting positions, alongside significant leadership roles at Moderna Therapeutics, bluebird bio, Takeda Pharmaceuticals, and Dyax. Barbara has a strong track record in establishing and directing pharmacovigilance activities across diverse biotech and pharmaceutical environments, focusing on compliance and safety metrics. Barbara's educational background includes an RN degree from Community Medical Center School of Nursing and an RN degree from Marywood University.